(Health-NewsWire.Net, May 20, 2016 ) Publisher's, 'Neisseria meningitidis Infections - Pipeline Review, H1 2016', provides an overview of the Neisseria meningitidis Infections pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Neisseria meningitidis Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Neisseria meningitidis Infections and features dormant and discontinued projects. Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Neisseria meningitidis Infections - The report reviews pipeline therapeutics for Neisseria meningitidis Infections by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Neisseria meningitidis Infections therapeutics and enlists all their major and minor projects - The report assesses Neisseria meningitidis Infections therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001239335/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Neisseria meningitidis Infections - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Neisseria meningitidis Infections pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001239335/sample
Table of Content: An Overview
Introduction 9 Publisher Report Coverage 9 Neisseria meningitidis Infections Overview 10 Therapeutics Development 11 Pipeline Products for Neisseria meningitidis Infections - Overview 11 Pipeline Products for Neisseria meningitidis Infections - Comparative Analysis 12 Neisseria meningitidis Infections - Therapeutics under Development by Companies 13 Neisseria meningitidis Infections - Therapeutics under Investigation by Universities/Institutes 14 Neisseria meningitidis Infections - Pipeline Products Glance 15 Late Stage Products 15 Clinical Stage Products 16 Early Stage Products 17 Neisseria meningitidis Infections - Products under Development by Companies 18 Neisseria meningitidis Infections - Products under Investigation by Universities/Institutes 19 Neisseria meningitidis Infections - Companies Involved in Therapeutics Development 20 Beijing Minhai Biotechnology Co., Ltd 20 Beijing Tiantan Biological Products Co., Ltd. 21 Biological E. Limited 22 GlaxoSmithKline Plc 23 ImmunoBiology Limited 24
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001239335/discount
JN-International Medical Corporation 25 MGB Biopharma Limited 26 Panacea Biotec Limited 27 Pfizer Inc. 28 Sanofi Pasteur SA 29 Serum Institute of India Limited 30 Wellstat Vaccines, LLC 31 Neisseria meningitidis Infections - Therapeutics Assessment 32 Assessment by Monotherapy Products 32 Assessment by Combination Products 33 Assessment by Target 34 Assessment by Mechanism of Action 36 Assessment by Route of Administration 37 Assessment by Molecule Type 39 Drug Profiles 41 (diphtheria + Haemophilus influenzae [serotype B] + hepatitis B + meningococcal [serotype C] + pertussis (whole-cell) + poliomyelitis + tetanus) (7-valent) vaccine - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 (meningococcal [serotype X] + tetanus) (monovalent) vaccine - Drug Profile 42 Product Description 42 Mechanism of Action 42 R&D Progress 42 MenBioVax - Drug Profile 43 Product Description 43 Mechanism of Action 43 R&D Progress 43
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001239335/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|